compounding glp-1 news New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA moves to stop compounding
Description
The findings of a new study suggest that an apparent association between GLP-1 medications and thyroid cancer may be due to more intensive patient screening, and not a side effect of the drugs themselves.
3. Personalised Treatment Plan
Glynn J
Do you have to take GLP-1 medications forever
Best selling author, Bren Brown, on the importance of getting back up and beginning again, when all our plans fail.
It works as an appetite suppressant,
